The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.00
Bid: 170.90
Ask: 171.00
Change: 2.30 (1.36%)
Spread: 0.10 (0.059%)
Open: 175.00
High: 175.00
Low: 170.00
Prev. Close: 168.70
N91 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Feb 2024 15:00

RNS Number : 2242C
Ninety One PLC
06 February 2024

Ninety One Limited Incorporated in the Republic of South Africa Registration number 2019/526481/06 JSE share code: NY1 ISIN: ZAE000282356

Ninety One plc Incorporated in England and Wales Registration number 12245293 LSE share code: N91 JSE share code: N91 ISIN: GB00BJHPLV88

Ninety One plc and Ninety One Limited (companies operating under a Dual Listed Companies structure ("DLC")) announce that Forty Two Point Two has increased its shareholding in Ninety One plc to 31.0402%, as set out below. In accordance with the operating conditions attached to the DLC, Forty Two Point Two's aggregate shareholding in the combined Ninety One plc and Ninety One Limited, following this announcement, is 26.7652% as calculated on a joint electorate basis. Shareholders should note that the UK Takeover Panel has confirmed that, for the purposes of the Rule 9.1 mandatory offer threshold, voting rights will be considered on a joint electorate basis.

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJHPLV88

Issuer Name

NINETY ONE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Forty Two Point Two

City of registered office (if applicable)

Ebene

Country of registered office (if applicable)

Mauritius

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

30 January 2024

6. Date on which Issuer notified

6 February 2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

31.0402

0.000000

31.0402

193,263,632

Position of previous notification (if applicable)

30.021748

0.000000

30.021748

186,922,794

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BJHPLV88

193,263,632

31.0402

Sub Total 8.A

193,263,632

31.0402%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

6 February 2024

13. Place Of Completion

London

Date of release: 6 February 2024

JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLZQLFBZLLLBBZ
Date   Source Headline
29th Apr 20241:00 pmRNSDealing in Securities by Employee Benefit Trusts
22nd Apr 20242:30 pmRNSDealing in Securities by Employee Benefit Trusts
16th Apr 20247:00 amRNSQ4 2024 AUM update
15th Apr 20242:00 pmRNSDealing in Securities by Employee Benefit Trusts
8th Apr 20242:00 pmRNSDealing In Securities by Employee Benefit Trusts
2nd Apr 20242:00 pmRNSDirector/PDMR Shareholding
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20241:00 pmRNSDirector/PDMR Shareholding
18th Mar 20242:00 pmRNSDealing In Securities by Employee Benefit Trusts
18th Mar 20242:00 pmRNSDealing In Securities by Employee Benefit Trusts
14th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
7th Mar 202412:00 pmRNSDirector/PDMR Shareholding
4th Mar 202412:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:00 pmRNSDirector/PDMR Shareholding
26th Feb 20242:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20242:00 pmRNSDirector/PDMR Shareholding
20th Feb 20242:00 pmRNSHolding(s) in Company
15th Feb 20243:00 pmRNSDirector/PDMR Shareholding
15th Feb 20243:00 pmRNSHolding(s) in Company
8th Feb 20242:00 pmRNSDirector/PDMR Shareholding
6th Feb 20243:00 pmRNSHolding(s) in Company
5th Feb 20242:00 pmRNSDirector/PDMR Shareholding
1st Feb 20242:00 pmRNSDirector/PDMR Shareholding
31st Jan 20242:00 pmRNSDealing in Securities by Employee Benefit Trusts
31st Jan 20242:00 pmRNSDealing in Securities by Employee Benefit Trusts
29th Jan 20242:00 pmRNSDirector/PDMR Shareholding
25th Jan 20242:00 pmRNSDirector/PDMR Shareholding
18th Jan 20241:00 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 2024 AUM update
16th Jan 20247:00 amRNS2023 AGM - Voting Results Update
5th Jan 20242:00 pmRNSDirector/PDMR Shareholding
11th Dec 20232:30 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSHalf-year Report and Dividend Declaration
3rd Nov 20237:05 amRNSTransaction in Own Shares
17th Oct 20237:00 amRNS2nd Quarter Update
2nd Oct 20232:30 pmRNSDirector/PDMR Shareholding
28th Sep 20232:30 pmRNSDirector/PDMR Shareholding
26th Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20232:00 pmRNSDirector/PDMR Shareholding
18th Sep 20232:00 pmRNSDirector/PDMR Shareholding
14th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20233:30 pmRNSCompany Secretary Change
11th Sep 20232:00 pmRNSDirector/PDMR Shareholding
7th Sep 20232:00 pmRNSDirector/PDMR Shareholding
29th Aug 20234:00 pmRNSHolding(s) in Company
24th Aug 20232:00 pmRNSDirector/PDMR Shareholding
24th Aug 20232:00 pmRNSDealing In Securities by Employee Benefit Trusts
21st Aug 20232:00 pmRNSDirector/PDMR Shareholding
17th Aug 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.